Medicines for Europe Better access. Better health is the new name of EGA.
The repositioning of the association as Medicines for Europe aims to drive greater healthcare efficiency through better health outcomes while providing solutions for the sustainability of European healthcare systems facing increased demographic demands on healthcare services.
‘Medicines for Europe Better access. Better health reflects our industries’ purpose and strategic objectives,’ said Medicines for Europe President, Jacek Glinka.
‘As an organisation we have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-makers to engage with us to deliver access to high quality medicines for all Europeans.’
Adrian van den Hoven, Medicines for Europe Director General, added, ‘Medicines for Europe is a great opportunity to build on the EGA’s established reputation for partnership
with stakeholders and authorities to deliver access to high quality medicines for patients, its commitment to the highest levels of quality, and to bringing even more value to
pharmaceuticals while bridging the sustainability of healthcare with a competitive pharmaceutical manufacturing industry.’
